Novartis vs Teva Pharmaceutical Industries
Novartis (NVS) and Teva Pharmaceutical Industries (TEVA) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $306B
- Last close
- $160.50
- 12 months
- +21.7%
- Market value
- $51.9B
- Last close
- $44.50
- 12 months
- +74.2%
At a glance
- By market value, Novartis ($306.3B) is about 5.9 times Teva Pharmaceutical Industries ($51.9B).
- Over the last 12 months Novartis's share price moved +21.7% and Teva Pharmaceutical Industries's +74.2%; against the S&P 500 that is +9.4 points and +62.0 points.
- In the last 90 days insiders reported 0 open-market purchases at Novartis and 0 at Teva Pharmaceutical Industries; members of Congress disclosed 0 trades in Novartis and 0 in Teva Pharmaceutical Industries.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Novartis NVSNYSE · Pharmaceutical Preparations | Teva Pharmaceutical Industries TEVANYSE · Pharmaceutical Preparations | |
|---|---|---|
| Size and profitability | ||
| Market value | $306B | $51.9B |
| Revenue, last fiscal year | — | $17.3B |
| Net income, last fiscal year | — | $1.41B |
| Net marginNet income as a share of revenue | — | 8.2% |
| Free cash flow | — | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How do Novartis and Teva Pharmaceutical Industries compare in size?
Novartis has the larger market value: Novartis $306B and Teva Pharmaceutical Industries $51.9B, at the last close.
Whose share price rose more over the last 12 months, NVS or TEVA?
Over the last 12 months Novartis moved +21.7% and Teva Pharmaceutical Industries +74.2%. Past price moves say nothing about the future.
Which has had more insider buying, Novartis or Teva Pharmaceutical Industries?
Since 2006, Teva Pharmaceutical Industries insiders reported 6 open-market purchases against 0 for Novartis. These are counts of what was filed, not a view on either stock.
Do members of Congress trade NVS or TEVA?
In the last 12 months, members of Congress disclosed 0 trades in Novartis (NVS) and 0 in Teva Pharmaceutical Industries (TEVA).
When did insiders last buy NVS and TEVA?
Novartis: no open-market purchase on record. Teva Pharmaceutical Industries: Sep 9, 2025.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Novartis pageTeva Pharmaceutical Industries pageRare insider trades this weekAll comparisons
https://oqro.io/compare/nvs-vs-teva